Branning Todd P.
- SEC CIK
- 0001765274
No open-market purchases or sales filed in the past year.
Current role at each company
- NBSE NeuBase Therapeutics, Inc.Chief Financial Officeras of Mar 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Branning Todd P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 (view filing) | Mar 18 | 3 days | Branning Todd P.Chief Financial Officer | PPurchase | +10.0K | $1.81 | +$18.1K | +50.0%30.0K after | |
| Mar 18, 2022 (view filing) | Mar 16-17 | 2 days | Branning Todd P.Chief Financial Officer | PPurchase | +20.0K | $1.68 | +$33.6K | New position20.0K after | 2 lots |